ストックスクリーナーアプリを入手
20.36
1.78%
-0.37
アフターアワーズ：
20.55
0.19
+0.93%
前日終値:
$20.73
開ける：
$20.83
24時間の取引高:
7.12M
Relative Volume:
0.80
時価総額：
$10.48B
収益：
$10.89B
当期純損益:
$-241.00M
株価収益率:
-76.66
EPS:
-0.2656
ネットキャッシュフロー:
$340.00M
1週間 パフォーマンス:
-4.59%
1か月 パフォーマンス:
+3.61%
6か月 パフォーマンス:
-16.90%
1年 パフォーマンス:
-42.26%
1日の値動き範囲:
$20.27
$21.16
1週間の範囲:
$20.20
$21.84
52週間の値動き範囲:
$17.40
$37.74
Baxter International Inc Stock (BAX) Company Profile
名前
Baxter International Inc
セクター
電話
(224) 948-2000
住所
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
20.36 | 10.67B | 10.89B | -241.00M | 340.00M | -0.2656 |
|
ISRG
Intuitive Surgical Inc
|
506.88 | 179.76B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
176.66 | 51.48B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
86.72 | 42.38B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
48.89 | 39.09B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
257.06 | 36.79B | 5.40B | 1.49B | 1.78B | 10.12 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-31 | ダウングレード | Argus | Buy → Hold |
| 2025-08-04 | ダウングレード | Stifel | Buy → Hold |
| 2025-08-01 | ダウングレード | Goldman | Buy → Neutral |
| 2025-02-26 | 再開されました | Goldman | Buy |
| 2025-02-24 | アップグレード | Argus | Hold → Buy |
| 2025-02-20 | 再開されました | Barclays | Overweight |
| 2024-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 開始されました | Goldman | Neutral |
| 2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-12-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-12-15 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-12-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-06-24 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | ダウングレード | Goldman | Neutral → Sell |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-18 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-18 | 繰り返されました | Raymond James | Outperform |
| 2022-02-18 | 繰り返されました | Stifel | Buy |
| 2022-02-18 | 繰り返されました | UBS | Neutral |
| 2022-02-18 | 繰り返されました | Wells Fargo | Overweight |
| 2022-02-11 | 開始されました | Goldman | Neutral |
| 2022-01-07 | 再開されました | Citigroup | Buy |
| 2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-09-03 | アップグレード | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | ダウングレード | UBS | Buy → Neutral |
| 2020-12-15 | ダウングレード | Goldman | Buy → Neutral |
| 2020-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2020-09-04 | ダウングレード | Argus | Buy → Hold |
| 2020-06-24 | 開始されました | Oppenheimer | Outperform |
| 2020-03-19 | アップグレード | Stifel | Hold → Buy |
| 2020-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-13 | 開始されました | Goldman | Buy |
| 2020-01-02 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-17 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-01-02 | アップグレード | Citigroup | Neutral → Buy |
| 2019-01-02 | アップグレード | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | アップグレード | Argus | Hold → Buy |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-05-17 | 再開されました | Piper Jaffray | Overweight |
| 2018-02-06 | 繰り返されました | Citigroup | Neutral |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2018-01-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
すべてを表示
Baxter International Inc (BAX) 最新ニュース
Baxter International Inc To Go Ex-Dividend On February 27th, 2026 With 0.01 USD Dividend Per Share - 富途牛牛
Ex-Dividend Reminder: MGE Energy, Labcorp Holdings and Baxter International - Nasdaq
Infusion Stand Market Is Going to Boom | BD • Baxter International • Smiths Medical - openPR.com
Baxter Investors Face a Test of Patience Amid Corporate Overhaul - AD HOC NEWS
Is Baxter International (BAX) Pricing In Its Turnaround After Years Of Share Price Weakness? - simplywall.st
Baxter International's $3 Billion Sales Base Facing Earnings Pressure - Smartkarma
Baxter is one of the S&P 500’s worst performers today. Earnings were brutal. - MSN
Baxter’s Ongoing Losses And Impairments Test The Investment Narrative - Yahoo Finance
Baxter International Inc. (BAX) Stock Analysis: Navigating Through Challenges with Strategic Resilience - DirectorsTalk Interviews
Is Baxter International Inc (BAX) Set to Underperform? Analyzing the Factors Limiting Growth - GuruFocus
Baxter Hopes Recovery Under New CEO, Faces Near-Term Pressure - Citeline News & Insights
Fill Finish Manufacturing Market Analysis Report 2026-2035: A $21+ Billion Market by 2030 with Johnson & Johnson, AbbVie, Thermo Fisher Scientific, BD & Co, Baxter, Lonza, and Catalent Leading - Yahoo Finance
Patient Lifting Equipment Market is Going to Boom | Baxter International Inc., ICU Medical, Inc., B. Braun Melsungen AG - openPR.com
The Top 5 Analyst Questions From Baxter's Q4 Earnings Call - Finviz
Global Blood Plasma Derivatives Market Size Projected to Reach $104.30 Billion by 2033; Immunoglobulins Drive Robust 9.08% CAGR – SNS Insider - GlobeNewswire Inc.
Benefits of Device Connectivity - Baxter
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Anti-Venom Market 2026-2035 Top Key Playres: Baxter - openPR.com
Demystifying Baxter International: Insights From 4 Analyst Reviews - Benzinga
Baxter International Inc (BAX) Shares Up 3.99% on Feb 17 - GuruFocus
BAX: Goldman Sachs Lowers Price Target on Baxter International | - GuruFocus
Baxter Restructuring And Divestiture Plan Tests Turnaround And Valuation Case - Sahm
Baxter International (BAX) Returns To Quarterly Loss And Tests Earnings Recovery Narrative - Sahm
Aug Sectors: Is Baxter International Inc a potential multi baggerJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - baoquankhu1.vn
Baxter International Inc. (NYSE:BAX) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
UBS Maintains Neutral on BAX Baxter International Inc. Feb 2026 - Meyka
Pale Fire Capital Bets Big on Healthcare With a 2.07 Million Share Baxter International (BAX) Investment - Yahoo Finance
Baxter’s New Decentralized Model Tests Earnings And Valuation Expectations - Yahoo Finance
Quarterly Trades: Does Baxter International Inc outperform in volatile marketsTrend Reversal & Daily Stock Trend Watchlist - baoquankhu1.vn
Why Baxter International Stock Was Tumbling Today - AOL.com
Is Baxter International Inc. stock a top momentum playJuly 2025 Weekly Recap & Real-Time Buy Signal Notifications - mfd.ru
Is Baxter International Inc. stock a momentum leaderJuly 2025 Weekly Recap & Weekly Watchlist of Top Performers - mfd.ru
Baxter Overhaul Shifts To Decentralized Model As Recovery Timelines Extend - simplywall.st
Is Baxter International Inc. stock risky to hold nowProduct Launch & AI Based Buy and Sell Signals - mfd.ru
Baxter International Inc.: How a 90-Year Medtech Veteran Is Rebuilding Its Product Playbook - AD HOC NEWS
Baxter International (NYSE:BAX) Price Target Lowered to $17.00 at The Goldman Sachs Group - MarketBeat
A Quick Look at Today's Ratings for Baxter International Inc(BAX.US), With a Forecast Between $20 to $25 - 富途牛牛
Baxter is the S&P 500’s worst performer today. Earnings were brutal. - MSN
Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Ultragenyx Pharmaceutical (RARE) - The Globe and Mail
The Truth About Baxter International Inc.: Hidden Healthcare Giant or Total Snooze Stock? - AD HOC NEWS
Baxter lays off 90 employees from hurricane-hit unit - Medical Buyer
Baxter International Earnings Call: Growth Meets Margin Squeeze - The Globe and Mail
BAX Q4 Deep Dive: Mixed Segment Performance and Margin Pressures Shape Outlook - Finviz
Looking Into Baxter International Inc's Recent Short Interest - Benzinga
Barclays Lowers Price Target for Baxter Intl (BAX) While Maintai - GuruFocus
Jefferies Financial Group Has Lowered Expectations for Baxter International (NYSE:BAX) Stock Price - MarketBeat
Barclays Has Lowered Expectations for Baxter International (NYSE:BAX) Stock Price - MarketBeat
Baxter sales up 8% to USD 2.97B in Q4 2025 - Medical Buyer
Baxter International Inc. (NYSE:BAX) Plans Quarterly Dividend of $0.01 - MarketBeat
Baxter International Inc. (NYSE:BAX) Q4 2025 Earnings Call Transcript - Insider Monkey
Baxter International Inc. (NYSE:BAX) Q4 2025 earnings call transcript - MSN
Baxter International Inc (BAX) 財務データ
収益
当期純利益
現金流量
EPS
2.48%
0.15%
大文字化:
|
ボリューム (24 時間):